Search Results 61-70 of 16953 for Linaclotide

  1. Nitisinone (oral route) - Side effects & dosage - Mayo Clinic

    Description. Nitisinone is used to treat hereditary tyrosinemia type 1, which is too much tyrosine in the blood. It helps to prevent high levels of tyrosine ...

  2. Non-Hodgkin Lymphoma Clinical Trials - Mayo Clinic Research

    Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...

  3. A Study of the Use of a Squatting Assist Device in Patients with Constipation - Mayo Clinic

    ... linaclotide, lubiprostone, and prucalopride to treat constipation will be eligible if can discontinue the medication at least 3 days (72 hrs.) before the ...

  4. Lenalidomide And Dexamethasone With Or Without Bortezomib In Treating Patients With Previously Untreated Multiple Myeloma - Mayo Clinic

    Biological therapies, such as lenalidomide, may stimulate the immune system in different ways and stop cancer cells from growing. Drugs used in chemotherapy, ...

  5. Cancer Treatment! Clinical Trials - Mayo Clinic Research

    Chemotherapy drugs, such as bacillus Calmette-Guerin (BCG), gemcitabine, docetaxel, and mitomycin C, work in different ways to stop the growth of tumor cells, ...

  7. Gastroenterology and Hepatology - Clinical trials

    Mayo Clinic's Division of Gastroenterology and Hepatology offers treatment and specialty care for people with a wide range of rare and common digestive ...

  8. Nutrition and healthy eating LGBTQ health - Mayo Clinic

    You can master healthy eating by learning how to plan meals and shop smart, and by practicing healthy-cooking techniques.

  9. Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma - Mayo Clinic

    RATIONALE: Lenalidomide may stimulate the immune system in different ways and stop cancer cells from growing. Monoclonal antibodies, such as rituximab, can ...

  10. Study Of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens In Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

    The purpose of this study is to assess the safety, tolerability and preliminary efficacy of nal-IRI in combination with 5-FU/LV and oxaliplatin in patients not ...